Skip to main content
2023 IKCS: Europe Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Video

Track: Oral Abstract

SESSION 4: ORAL ABSTRACTS

Friday, April 21, 2023
14:15 – 15:15 GMT
Location: Lenox 3
CE: 1

    Moderator(s)

  • Gabriel Malouf, MD, PhD

    Institut de Cancérologie de Strasbourg-Europe, Strasbourg University, France

  • Lars Lund, MD, PhD

    Professor, Head of research,
    University of Southern Denmark
    University of Southern Denmark
    Odense, Syddanmark, Denmark

Presentations:

  • 14:17 – 14:27 GMT
    Oral Abstract: Cross-trial propensity score weighted analysis of nivolumab plus ipilimumab versus nivolumab monotherapy for patients with untreated advanced renal cell carcinoma

    Lead Author: Michael B. Atkins, MD (he/him/his) – Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.

  • 14:27 – 14:37 GMT
    Oral Abstract: Health Related Quality of Life (HR-QOL) Measures in Renal Cell Carcinoma: Patient-reported relevance of items of the FKSI-19, EORTC QLQ-C30 and EQ-5D.

    Lead Author: Benjamin D. Mercier, BS (he/him/his) – City of Hope Comprehensive Cancer Center

  • 14:37 – 14:47 GMT
    Oral Abstract: Patients’ experiences on the course of treatment after partial nephrectomy or percutaneous cryoablation of small renal cell carcinoma - a cross-sectional multicenter study

    Lead Author: Theresa Junker, PhD – Research and Innovation Unit of Radiology

  • 14:47 – 14:57 GMT
    Oral Abstract: Eosinophilic solid and cystic renal cell carcinoma : a rare new entity associated with TSC1/TSC2 genetic alteration and rare metastatic potential.

    Lead Author: Virginie Verkarre, MD PhD (she/her/hers) – APHP-Centre, Université de Paris-Cité, INSERM UMR970

  • 14:57 – 15:07 GMT
    Oral Abstract: Baseline circulating soluble factors as predictors of benefit from nivolumab in metastatic renal cell carcinoma (mRCC): additional multivariate analyses of the pooled translational NIVOREN GETUG-AFU26 population

    Lead Author: Lucia Carril Ajuria, MD (she/her/hers) – Institute Gustave Roussy /CHU St Pierre-CHU Brugmann

  • 15:07 – 15:15 GMT
    Session 4 Q&A

    Moderator: Gabriel Malouf, MD, PhD – Institut de Cancérologie de Strasbourg-Europe, Strasbourg University

    Moderator: Lars Lund, MD, PhD – University of Southern Denmark